Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
176517-01-4----1件: 77 💬
281409-90-7----1件: 77 💬
3[14C]-ONO-5788----1件: 77 💬
4[CAM2029 ]----1件: 77 💬
5[CAM2029]----1件: 77 💬
6[CRN00808]----1件: 77 💬
7[ISIS 766720]----1件: 77 💬
8Acetaminophen1件: Acetaminophen1件: Acetaminophen 💬 2件: PTGS1,
PTGS2 💬 		23件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis - DNA adducts, Efferocytosis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Platelet activation, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 💬19件: 11, 13, 19, 34, 35, 46, 49, 51, 63, 70, 77, 86, 96, 222, 231, 256, 271, 300, 337 💬
9Acetate1件: Acetate---52件: 1, 2, 6, 10, 11, 13, 22, 35, 40, 46, 49, 51, 60, 63, 64, 65, 66, 67, 70, 71, 73, 75, 76, 77, 78, 79, 81, 83, 85, 86, 88, 89, 90, 96, 97, 113, 145, 156, 158, 162, 171, 206, 222, 223, 224, 225, 227, 235, 251, 265, 298, 299 💬
10Acetato de octreótida----1件: 77 💬
11Adipose Tissue Biopsy----1件: 77 💬
12Alesse----1件: 77 💬
13ALXN2420----1件: 77 💬
14ATL1103----1件: 77 💬
15AVANDIA*28CPR RIV 4MG----1件: 77 💬
16Behavioral: Home administration----1件: 77 💬
17BIM 23A760----1件: 77 💬
18BIM23A760----1件: 77 💬
19BIM23B065----1件: 77 💬
20Blood sample----33件: 2, 3, 6, 8, 10, 13, 14, 19, 34, 46, 48, 49, 51, 53, 61, 63, 65, 66, 67, 77, 79, 84, 88, 96, 97, 107, 113, 127, 195, 206, 235, 274, 299 💬
21Blood tests: IGF-1, AST/ALT/ALP/TBIL, GTT----1件: 77 💬
22C2L-OCT-01 PR----1件: 77 💬
23C2L-OCT-01 PR , 10mg----1件: 77 💬
24C2L-OCT-01 PR , 20mg----1件: 77 💬
25C2L-OCT-01 PR , 30mg----1件: 77 💬
26C2L-OCT-01 PR 30 mg----1件: 77 💬
27C2L-OCT-01 PR, 10 or 20 mg----1件: 77 💬
28C2L-OCT-01 PR, 20 mg----1件: 77 💬
29C2L-OCT-01 PR, 30 mg----1件: 77 💬
30Cabaser----2件: 6, 77 💬
31Cabergolin----2件: 74, 77 💬
32Cabergoline1件: Cabergoline1件: Cabergoline 💬 2件: DRD2,
PRL 💬 		14件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬4件: 6, 74, 75, 77 💬
33CAM2029----1件: 77 💬
34CAM2029 (Octreotide subcutaneous depot)1件: Octreotide5件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
35CAM2029 (Octreotide subcutaneous depot) _prefilled syringe_prefilled syringe1件: Octreotide5件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
36CAM2029 (Octreotide subcutaneous depot)_ prefilled pen1件: Octreotide5件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
37CAM2029 (Octreotide subcutaneous depot)_ prefilled syringe1件: Octreotide5件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
38CAM2029 (Octreotide subcutaneous depot)_pre-filled pen1件: Octreotide5件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
39CAM2029 (Octreotide subcutaneous depot)_pre-filled syringe1件: Octreotide5件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
40CAM2029 (Octreotide subcutaneous depot)_prefilled pen1件: Octreotide5件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
41CAM2029 (Octreotide subcutaneous depot)_prefilled syringe1件: Octreotide5件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
42CAM2029-BR----1件: 77 💬
43CIALIS - 20 MG 2 COMPRESSE RIVESTITE CON FILM IN BLISTER USO ORALE----2件: 75, 77 💬
44Clomiphene citrate----2件: 74, 77 💬
45CMRI----1件: 77 💬
46Combination with dopamine agonist cabergoline2件: Cabergoline,
Dopamine		3件: Dopamine hydrochloride ,
Cabergoline ,
Dopamine 💬 		6件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5,
PRL 💬 		17件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Hormone signaling, JAK-STAT signaling pathway, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 77 💬
47Combination with somatostatin analogue octreotide2件: Octreotide,
Somatostatin		6件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Somatostatin ,
Octreotide hydrochloride 💬 		5件: SSTR1,
SSTR2,
SSTR3,
SSTR4,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
48CRN00808----1件: 77 💬
49CRN00808 - is an oral non-peptide small molecule somatostatin receptor 2 (SST2)1件: Somatostatin1件: Somatostatin 💬 5件: SSTR1,
SSTR2,
SSTR3,
SSTR4,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
50CRN00808 is an oral non-peptide small molecule somatostatin receptor 2 (SST2) agonist1件: Somatostatin1件: Somatostatin 💬 5件: SSTR1,
SSTR2,
SSTR3,
SSTR4,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
51CRN00808 è un agonista del recettore 2 della somatostatina (SST2), orale, non peptidico a piccole dimensioni molecolari1件: Somatostatin1件: Somatostatin 💬 5件: SSTR1,
SSTR2,
SSTR3,
SSTR4,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
52CRN00808.HCl----1件: 77 💬
53Cyclo ((diaminoethyl-carbamate)HyPro-Phg-(D) Trp-Ly pamoate----1件: 77 💬
54Cyclo((diaminoethyl-carbamate)HyPro-Phg-(D)Trp-Ly pamoate----1件: 77 💬
55Cyclo((diaminoethyl-carbamate)HyPro-Phg-(D)Trp-Lys pamoate----1件: 77 💬
56Cyclo((diaminoethyl-carbamate)HyPro-Phg-(D)Trp-Lys-Tyr(Bzl)-Phe) pamoate----1件: 77 💬
57Cyclo(diaminoethyl-carbamate)HyPro-Phg-(D)Trp-Lys-Tyr(Bzl)-Phe)----2件: 75, 77 💬
58D-Phenylalanyl-L-h----1件: 77 💬
59D-Phenylalanyl-L-he----1件: 77 💬
60D-Phenylalanyl-L-hemicystyl-L-phenylalanyl-D-trypto----1件: 77 💬
61D-Phenylalanyl-L-hemicystyl-L-phenylalanyl-D-tryptophan2件: D-Tryptophan,
Tryptophan		1件: Tryptophan 💬 --1件: 77 💬
62D-Phenylalanyl-L-hemicystyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-L-hemiscystyl-L-threonino----1件: 77 💬
63D-Tryptophan2件: D-Tryptophan,
Tryptophan		1件: Tryptophan 💬 --1件: 77 💬
64Debio 4126----1件: 77 💬
65Denosumab1件: Denosumab1件: Denosumab 💬 1件: TNFSF11 💬 8件: Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬11件: 46, 50, 70, 75, 77, 93, 95, 96, 223, 274, 299 💬
66DG3173----1件: 77 💬
67Diagnostic Test: Oral Glucose Tolerance Test----6件: 6, 13, 57, 65, 77, 299 💬
68Diagnostic Test: Radiological tests----1件: 77 💬
69Diagnostic Test: Subcutaneous administration of recombinant human IGF-1----1件: 77 💬
70Diagnostic Test: Total body magnetic resonance imaging----1件: 77 💬
71Direct surgery for acromegaly----1件: 77 💬
72Dopamine1件: Dopamine2件: Dopamine hydrochloride ,
Dopamine 💬 		5件: DRD1,
DRD2,
DRD3,
DRD4,
DRD5 💬 		13件: Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬5件: 6, 7, 17, 74, 77 💬
73Dopastatin1件: Dopastatin---1件: 77 💬
74DOSTINEX----2件: 75, 77 💬
75Dostinex 0,5 mg Tabletten----1件: 77 💬
76Dostinex 0.5mg tabletts----1件: 77 💬
77DOSTINEX 2CPR 0,5MG----1件: 77 💬
78Empagliflozin1件: Empagliflozin1件: Empagliflozin 💬 --17件: 28, 46, 57, 58, 65, 67, 72, 77, 86, 96, 97, 113, 222, 223, 257, 298, 299 💬
79Escitalopram1件: Escitalopram2件: Escitalopram oxalate ,
Escitalopram 💬 		1件: SLC6A4 💬 3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬5件: 2, 6, 13, 46, 77 💬
80Escitalopram 10 mg1件: Escitalopram2件: Escitalopram oxalate ,
Escitalopram 💬 		1件: SLC6A4 💬 3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 77 💬
81Escitalopram Hexal 10 mg1件: Escitalopram2件: Escitalopram oxalate ,
Escitalopram 💬 		1件: SLC6A4 💬 3件: Neuroactive ligand signaling, Serotonergic synapse, Synaptic vesicle cycle 💬1件: 77 💬
82Evista 60mg film-coated tablets----1件: 77 💬
83Furosemide1件: Furosemide1件: Furosemide 💬 1件: SLC12A2 💬 3件: Pancreatic secretion, Salivary secretion, Vibrio cholerae infection 💬5件: 6, 57, 77, 86, 222 💬
84Gadolinium1件: Gadolinium---8件: 13, 34, 46, 65, 77, 86, 113, 305 💬
85Genotropin----6件: 13, 77, 107, 187, 193, 222 💬
86GHR-LRX----1件: 77 💬
87Gold1件: Gold---71件: 2, 5, 6, 11, 13, 17, 19, 21, 22, 28, 34, 35, 46, 49, 50, 53, 54, 56, 57, 58, 60, 63, 64, 65, 66, 68, 71, 75, 76, 77, 79, 84, 85, 86, 88, 91, 93, 95, 96, 97, 98, 107, 113, 127, 137, 158, 162, 167, 171, 193, 206, 215, 218, 222, 223, 224, 226, 227, 228, 230, 235, 271, 291, 294, 296, 298, 299, 310, 318, 331, 340 💬
88Growth Hormone Receptor Antagonist----1件: 77 💬
89H01C B03----1件: 77 💬
90Implante de Octreótida----1件: 77 💬
91Injectable Somatostatin Analogs (octreotide or lanreotide)3件: Lanreotide,
Octreotide,
Somatostatin		7件: Octreotide ,
Octreotide acetate ,
Lanreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Somatostatin ,
Octreotide hydrochloride 💬 		5件: SSTR1,
SSTR2,
SSTR3,
SSTR4,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
92Insulin----6件: 6, 13, 46, 75, 77, 299 💬
93IONIS GHR-LRx----1件: 77 💬
94IONIS-GHR-LRx----1件: 77 💬
95IPSTYL----1件: 77 💬
96IPSTYL - 60 MG SOLUZIONE INIETTABILE PER USO SOTTOCUTANEO 1 SIRINGA PRERIEMPITA----1件: 77 💬
97IPSTYL - 90 MG SOLUZIONE INIETTABILE PER USO SOTTOCUTANEO 1 SIRINGA PRERIEMPITA----1件: 77 💬
98Ipstyl 120 mg----1件: 77 💬
99Ipstyl 90 mg----1件: 77 💬
100Ipstyl Autogel----1件: 77 💬
101ISIS 766720----1件: 77 💬
102It is a chimera of a Dopamin 2 and an Somatostatin 2 receptor agonist1件: Somatostatin1件: Somatostatin 💬 5件: SSTR1,
SSTR2,
SSTR3,
SSTR4,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
103ITF2984----1件: 77 💬
104ITF2984 1000 mcg----1件: 77 💬
105ITF2984 2000 mcg----1件: 77 💬
106ITF2984 500 mcg----1件: 77 💬
107ITF2984 diacetate----1件: 77 💬
108Ketogenic Diet----7件: 13, 21, 49, 77, 127, 145, 148 💬
109LANREOTIDA----1件: 77 💬
110Lanreotida Autogel 120 mg----1件: 77 💬
111Lanreotide1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬5件: 67, 73, 77, 85, 298 💬
112Lanreotide (Autogel formulation)1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
113Lanreotide (Autogel formulation), duration of treatment 24-56 weeks, depending on dose interval1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
114Lanreotide (Autogel formulation), duration of treatment 46-48 weeks1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
115Lanreotide 60Mg Solution for Injection1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
116LANREOTIDE ACETATE2件: Acetate,
Lanreotide		1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬4件: 67, 77, 85, 298 💬
117LANREOTIDE ACETATO1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
118Lanreotide ATG1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
119Lanreotide ATG 120mg1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
120Lanreotide autogel1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
121Lanreotide Autogel 120 mg1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
122Lanreotide Autogel 120mg1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
123Lanreotide Autogel and Octreotide LAR2件: Lanreotide,
Octreotide		6件: Octreotide ,
Octreotide acetate ,
Lanreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
124Lanreotide Autogel®1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
125Lanreotide PRF1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
126Lanreotide-Autogel 120 mg1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
127Liraglutide1件: Liraglutide1件: Liraglutide 💬 1件: GLP1R 💬 4件: Hormone signaling, Insulin secretion, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬5件: 6, 13, 75, 77, 193 💬
128MAR002----1件: 77 💬
129Medical History, demographics----1件: 77 💬
130Medications for acromegaly----1件: 77 💬
131Mediterranean Diet----4件: 13, 77, 97, 265 💬
132Metformin1件: Metformin2件: Metformin hydrochloride ,
Metformin 💬 		2件: PRKAA1,
PRKAA2 💬 		20件: AMPK signaling pathway, Adipocytokine signaling pathway, Alcoholic liver disease, Apelin signaling pathway, Autophagy - animal, Circadian rhythm, Fluid shear stress and atherosclerosis, FoxO signaling pathway, Glucagon signaling pathway, Hypertrophic cardiomyopathy, Insulin resistance, Insulin signaling pathway, Longevity regulating pathway, Longevity regulating pathway - multiple species, Non-alcoholic fatty liver disease, Oxytocin signaling pathway, PI3K-Akt signaling pathway, Thermogenesis, Tight junction, mTOR signaling pathway 💬31件: 2, 6, 8, 13, 46, 49, 60, 65, 66, 67, 74, 75, 77, 81, 84, 85, 86, 97, 113, 127, 158, 206, 218, 222, 225, 233, 265, 285, 298, 299, 301 💬
133MRI----6件: 13, 48, 70, 77, 85, 278 💬
134Mycapssa----1件: 77 💬
135Mycapssa?----1件: 77 💬
136Mycapssa®----1件: 77 💬
137Mycapssa™----1件: 77 💬
138Octreolin----1件: 77 💬
139Octreotid----1件: 77 💬
140OCTREOTIDA1件: Octreotide5件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
141OCTREOTIDA ACETATO1件: Octreotide5件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
142Octreotidacetat----1件: 77 💬
143Octreotide1件: Octreotide5件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬8件: 67, 75, 77, 84, 85, 89, 193, 227 💬
144OCTREOTIDE ACETATE2件: Acetate,
Octreotide		5件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 77, 227 💬
145Octreotide acetate 30 mg suspension2件: Acetate,
Octreotide		5件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
146Octreotide acetate and cabergoline/Octrotide and Somavert3件: Acetate,
Cabergoline,
Octreotide		6件: Octreotide ,
Cabergoline ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		3件: DRD2,
PRL,
SSTR2 💬 		16件: Alcoholism, Cocaine addiction, Cytokine-cytokine receptor interaction, Dopaminergic synapse, Gap junction, Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway, Parkinson disease, Prolactin signaling pathway, Rap1 signaling pathway, cAMP signaling pathway 💬1件: 77 💬
147Octreotide acetate LAR2件: Acetate,
Octreotide		5件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
148Octreotide Acetate Microspheres for Injection injection2件: Acetate,
Octreotide		5件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
149Octreotide acetate prolonged release, 30 mg2件: Acetate,
Octreotide		5件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
150OCTREOTIDE ACETATO1件: Octreotide5件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 77, 227 💬
151Octreotide capsules1件: Octreotide5件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
152Octreotide FluidCrystal® injection depot1件: Octreotide5件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
153OCTREOTIDE HYDROCHLORIDE1件: Octreotide5件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
154Octreotide Implant1件: Octreotide5件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
155Octreotide LAR1件: Octreotide5件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬3件: 67, 77, 227 💬
156Octreotide LAR 30 MG Injection1件: Octreotide5件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
157Octreotide LAR 30mg1件: Octreotide5件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
158Octreotide subcutaneous depot1件: Octreotide5件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
159Octreotide-LAR1件: Octreotide5件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 67, 77 💬
160Octreotide-LAR or lanreotide2件: Lanreotide,
Octreotide		6件: Octreotide ,
Octreotide acetate ,
Lanreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
161OGTT----1件: 77 💬
162ONO-5788----1件: 77 💬
163Other: 1H/31P Magnetic Resonance Spectroscopy----1件: 77 💬
164Other: Blood draw----17件: 2, 6, 11, 13, 18, 39, 46, 57, 77, 84, 85, 86, 88, 96, 97, 167, 299 💬
165Other: MRI, dual-energy, x-ray absorptiometry, muscle ultrasounds, blood testing----2件: 75, 77 💬
166Other: Oral Glucose Tolerance Test (OGTT)----1件: 77 💬
167Other: oral glucose tolerance testing----1件: 77 💬
168Other: Performed 2 diagnostic tests (2 OGTT tests with 75g of Glucose)----1件: 77 💬
169Other: Questionnaires----8件: 3, 6, 13, 41, 46, 77, 96, 226 💬
170Other: Thyroid sonography----1件: 77 💬
171Paltusotine1件: Paltusotine2件: Paltusotine ,
Paltusotine hydrochloride 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
172Paltusotine (Free base)1件: Paltusotine2件: Paltusotine ,
Paltusotine hydrochloride 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
173PaltusotineProduct Code: CRN00808Pharmaceutical Form: TabletINN or Proposed INN: Paltusotine (Free base)CAS Number: 2172870-89-0Current Sponsor code: CRN00808Other descriptive name: PaltusotineConcentration unit: mg milligram(s)Concentration type: equalConcentration number: 20-Pharmaceutical form of the placebo: TabletRoute of administration of the placebo: Oral use1件: Paltusotine2件: Paltusotine ,
Paltusotine hydrochloride 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
174Pasireotida----2件: 75, 77 💬
175Pasireotide1件: Pasireotide3件: Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬 		4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬4件: 67, 74, 75, 77 💬
176Pasireotide (SOM230), Octreotide (Sandostatin)2件: Octreotide,
Pasireotide		8件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate ,
Octreotide hydrochloride 💬 		4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
177Pasireotide 20mg1件: Pasireotide3件: Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬 		4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 75, 77 💬
178Pasireotide 40mg1件: Pasireotide3件: Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬 		4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 75, 77 💬
179Pasireotide 60mg1件: Pasireotide3件: Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬 		4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 75, 77 💬
180PASIREOTIDE DIASPARTATE1件: Pasireotide3件: Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬 		4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 75, 77 💬
181Pasireotide LAR1件: Pasireotide3件: Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬 		4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬3件: 67, 75, 77 💬
182Pasireotide LAR 60 mg1件: Pasireotide3件: Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬 		4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
183Pasireotide long acting release formulation1件: Pasireotide3件: Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬 		4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
184PASIREOTIDE PAMOATE1件: Pasireotide3件: Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬 		4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 75, 77 💬
185Pasireotide s.c.1件: Pasireotide3件: Pasireotide ,
Pasireotide diaspartate ,
Pasireotide pamoate 💬 		4件: SSTR1,
SSTR2,
SSTR3,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 75, 77 💬
186PEGVISOMANT1件: Pegvisomant1件: Pegvisomant 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬2件: 77, 265 💬
187Pegvisomant (somavert)1件: Pegvisomant1件: Pegvisomant 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 77 💬
188Pegvisomant treatment1件: Pegvisomant1件: Pegvisomant 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 77 💬
189Pegvisomant/ Sandostatin LAR1件: Pegvisomant1件: Pegvisomant 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 77 💬
190PN-800467----1件: 77 💬
191Pre-treatment with octreotide1件: Octreotide5件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
192Preoperative lanreotide treatment1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
193Radiation: Gamma knife radiosurgery----1件: 77 💬
194Radiation: radiotherapy----1件: 77 💬
195Raloxifene1件: Raloxifene2件: Raloxifene hydrochloride ,
Raloxifene 💬 		2件: ESR1,
ESR2 💬 		10件: Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Estrogen signaling pathway, GnRH secretion, Hormone signaling, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬2件: 46, 77 💬
196Recombinant human growth hormone----4件: 77, 193, 265, 276 💬
197Rosiglitazone1件: Rosiglitazone2件: Rosiglitazone maleate ,
Rosiglitazone 💬 		1件: PPARG 💬 12件: AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬7件: 46, 57, 75, 77, 97, 222, 265 💬
198Saline----12件: 2, 6, 13, 17, 18, 53, 67, 77, 86, 97, 168, 299 💬
199Sandostatin----1件: 77 💬
200Sandostatin (Octreotide Acetate)2件: Acetate,
Octreotide		5件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
201Sandostatin LAR----5件: 67, 77, 84, 193, 227 💬
202SANDOSTATIN LAR 10 mg polvo para suspensión inyectable----1件: 77 💬
203Sandostatin LAR 10mg----1件: 77 💬
204SANDOSTATIN LAR 20 mg polvo para suspensión inyectable----1件: 77 💬
205Sandostatin LAR 20mg----1件: 77 💬
206Sandostatin LAR 20mg, 30mg----1件: 77 💬
207SANDOSTATIN LAR 30 mg polvo para suspensión inyectable----1件: 77 💬
208Sandostatin LAR 30mg----1件: 77 💬
209Sandostatin LAR Depot----1件: 77 💬
210Sandostatin LAR Depot versus transsphenoidal surgery----1件: 77 💬
211Sandostatin LAR Injection, 10mg, 20mg, 30mg----1件: 77 💬
212Sandostatin LAR Monatsdepot 20 mg----1件: 77 💬
213Sandostatin LAR ®----1件: 77 💬
214Sandostatin LAR ® (octreotide acetate LAR) 30 MG2件: Acetate,
Octreotide		5件: Octreotide ,
Octreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Octreotide hydrochloride 💬 		1件: SSTR2 💬 5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
215Sandostatin LAR, 10 mg, 20 mg and 30 mg----1件: 77 💬
216Sandostatin LAR-Monatsdepot----1件: 77 💬
217Sandostatin LAR-Monatsdepot 10 mg----1件: 77 💬
218Sandostatin LAR-Monatsdepot 20 mg----1件: 77 💬
219Sandostatin LAR-Monatsdepot 30 mg----1件: 77 💬
220Sandostatin LAR®----1件: 77 💬
221Sandostatin ® injection----1件: 77 💬
222Sandostatina----2件: 67, 77 💬
223SANDOSTATINA - LAR 10 MG/2 ML POLVERE E SOLVENTE PER SOSPENSIONE INIETTABILE 1 FLACONE + 2 FIALE DA 2 ML + SET DA INIEZIONE----1件: 77 💬
224SANDOSTATINA - LAR 10 MG/2.5 ML POLVERE E SOLVENTE PER SOSPENSIONE INIETTABILE FLACONE POLVERE + SIRINGA PRERIEMPITA 2.5 ML + 2 AGHI----1件: 77 💬
225SANDOSTATINA - LAR 20 MG/2.5 ML POLVERE E SOLVENTE PER SOSPENSIONE INIETTABILE FLACONE POLVERE + SIRINGA PRERIEMPITA 2.5 ML + 2 AGHI----2件: 67, 77 💬
226SANDOSTATINA - LAR 30 MG/2 ML POLVERE E SOLVENTE PER SOSPENSIONE INIETTABILE 1 FLACONE + 2 FIALE DA 2 ML + SET DA INIEZIONE----1件: 77 💬
227SANDOSTATINA - LAR 30 MG/2.5 ML POLVERE E SOLVENTE PER SOSPENSIONE INIETTABILE FLACONE POLVERE + SIRINGA PRERIEMPITA 2.5 ML + 2 AGHI----1件: 77 💬
228SANDOSTATINA LAR----2件: 67, 77 💬
229SANDOSTATINA LAR IM FL 20MG 2F----1件: 77 💬
230Sandostatine L.P. 10 mg, poudre et solvant en seringue préremplie pour suspension injectable (IM)----1件: 77 💬
231Sandostatine L.P. 20 mg, poudre et solvant en seringue préremplie pour suspension injectable (IM)----1件: 77 💬
232Sandostatine L.P. 30 mg, poudre et solvant en seringue----1件: 77 💬
233Sandostatine L.P. 30 mg, poudre et solvant pour suspension injectable à libération prolongée----1件: 77 💬
234Sandostatine LAR 20 mg----1件: 77 💬
235Sandostatine Long Acting Repeatable 30 mg----1件: 77 💬
236Sandostatin® LAR----1件: 77 💬
237Sandostatin® LAR®-Monatsdepot 10 mg----1件: 77 💬
238Sandostatin® LAR®-Monatsdepot 20 mg----1件: 77 💬
239Sandostatin® LAR®-Monatsdepot 30 mg----1件: 77 💬
240Sign and symptoms: questionnaire----1件: 77 💬
241SIGNIFOR----2件: 75, 77 💬
242Sitagliptin1件: Sitagliptin3件: Sitagliptin phosphate ,
Sitagliptin ,
Sitagliptin phosphate 💬 		1件: DPP4 💬 2件: Protein digestion and absorption, Virion - Hepatitis viruses 💬6件: 6, 63, 75, 77, 233, 299 💬
243SMS995----1件: 77 💬
244SMS995B----1件: 77 💬
245SOM022----1件: 77 💬
246SOM230----3件: 74, 75, 77 💬
247SOM230 LAR----2件: 75, 77 💬
248SOM230 LAR, 20 mg----2件: 75, 77 💬
249SOM230, 300micrograms----2件: 75, 77 💬
250SOM230, 600 micrograms----2件: 75, 77 💬
251SOM230, 900 micrograms----2件: 75, 77 💬
252SOM230B----2件: 75, 77 💬
253SOM230C----1件: 77 💬
254Somatostatin1件: Somatostatin1件: Somatostatin 💬 5件: SSTR1,
SSTR2,
SSTR3,
SSTR4,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬2件: 67, 77 💬
255Somatostatin analog (lanreotide or octreotide)3件: Lanreotide,
Octreotide,
Somatostatin		7件: Octreotide ,
Octreotide acetate ,
Lanreotide acetate ,
Octreotide pamoate ,
Octreotide acetate ,
Somatostatin ,
Octreotide hydrochloride 💬 		5件: SSTR1,
SSTR2,
SSTR3,
SSTR4,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
256Somatostatin Receptor Ligand (SRL)1件: Somatostatin1件: Somatostatin 💬 5件: SSTR1,
SSTR2,
SSTR3,
SSTR4,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
257SOMATULINA AUTOGEL----1件: 77 💬
258Somatuline ATG----1件: 77 💬
259Somatuline Autogel----2件: 67, 77 💬
260Somatuline Autogel (lanreotide acetate)2件: Acetate,
Lanreotide		1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
261Somatuline Autogel 120----1件: 77 💬
262SOMATULINE AUTOGEL 120 mg----1件: 77 💬
263Somatuline Autogel 120mg----1件: 77 💬
264Somatuline Autogel 60mg----1件: 77 💬
265Somatuline Autogel 90mg----1件: 77 💬
266Somatuline Autogel Injectable 120----1件: 77 💬
267Somatuline Autogel® (lanreotide) 60, 90, 120 mg.1件: Lanreotide1件: Lanreotide acetate 💬 2件: SSTR2,
SSTR5 💬 		5件: Gastric acid secretion, Growth hormone synthesis, secretion and action, Hormone signaling, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬1件: 77 💬
268Somatuline Autogel® 60, 90 or 120 mg----1件: 77 💬
269SOMATULINE L.P. 120 mg, solution injectable à libération prolongée en seringue préremplie----1件: 77 💬
270Somatuline LP 120mg----1件: 77 💬
271SOMATULINE® AUTOGEL® 120 mg solution for injection----1件: 77 💬
272SOMAVERT----1件: 77 💬
273Somavert (Pegvisomant)1件: Pegvisomant1件: Pegvisomant 💬 1件: GHR 💬 6件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, Hormone signaling, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 💬1件: 77 💬
274Somavert 10 mg----1件: 77 💬
275SOMAVERT 15 mg----1件: 77 💬
276SOMAVERT 20 mg----1件: 77 💬
277Surgery for acromegaly----1件: 77 💬
278SYHX2008----1件: 77 💬
279SYHX2008 injection----1件: 77 💬
280Tadalafil1件: Tadalafil1件: Tadalafil 💬 1件: PDE5A 💬 2件: Purine metabolism, cGMP-PKG signaling pathway 💬8件: 6, 51, 75, 77, 84, 86, 113, 210 💬
281TE-8214 - SAD----1件: 77 💬
282Transcranial Magnetic Stimulation----2件: 13, 77 💬
283Transnasal butterfly surgery----1件: 77 💬
284Transsphenoidal adenomectomy----1件: 77 💬
285Transsphenoidal surgery----1件: 77 💬
286Tryptophan1件: Tryptophan1件: Tryptophan 💬 --3件: 6, 46, 77 💬
287UnK----1件: 77 💬
288Zoledronic acid1件: Zoledronic acid5件: Zoledronic acid ,
Zoledronate disodium ,
Zoledronate trisodium ,
Zoledronic acid ,
Zoledronic acid hemipentahydrate 💬 		1件: FDPS 💬 3件: Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬16件: 5, 6, 13, 17, 46, 75, 77, 93, 95, 96, 97, 270, 274, 282, 299, 333 💬